Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $171.9M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 5.88B 1.26B Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Fujifilm JPY 3.69T 340.04B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026
Xencor USD 893M 200M Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026